Ishii Midori 石井翠

Researcher Number	50637866
Other IDs
Affiliation (Current)	2026: 順天堂大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help	2024 – 2025: 順天堂大学, 医学部, 准教授 2022 – 2023: 順天堂大学, 医学部, 助教 2019 – 2021: 順天堂大学, 順天堂大学血液内科, 特別研究員(RPD)
Review Section/Research Field	Principal Investigator Basic Section 56020:Orthopedics-related / Basic Section 56020:Orthopedics-related / Basic Section 50020:Tumor diagnostics and therapeutics-related Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator Ewing肉腫 / iPS細胞 / 免疫細胞療法 / iPSC / ゲノム編集方法 / TCR-T / 細胞傷害性T細胞療法 / CTL / ネオアンチゲン / 細胞傷害性T細胞 Except Principal Investigator CD4/CD8 lineage choice / CD4 Th1 / iPS細胞由来T細胞

他家iPSC由来HLA-A*0201拘束性TCR-T細胞療法のためのHLAゲノム編集技術の開発Principal Investigator
- Principal Investigator
  
  石井翠
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56020:Orthopedics-related
- Research Institution
  Juntendo University
The investigation of CD4/CD8 lineage choice and Th1 generation from iPSC
- Principal Investigator
  
  安藤美樹
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Juntendo University
Development of HLA-A24-restricted neoantigen-specific immunotherapy for Ewing sarcomaPrincipal Investigator
- Principal Investigator
  
  Ishii Midori
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Juntendo University
Development of the fusion gene-specific rejuvenated CTL therapy for Ewing sarcomaPrincipal Investigator
- Principal Investigator
  
  石井翠
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for JSPS Fellows
- Review Section
  
  Basic Section 56020:Orthopedics-related
- Research Institution
  Juntendo University

All 2024 2021 2020 2019

All Journal Article Presentation Patent

[Journal Article] L-asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein-Barr virus infection2024
- Author(s)
  Yoshiki Furukawa, Jun Ando, Midori Ishii, Shintaro Kinoshita, Ayaka Goto, Kota Tachibana, Yoko Azusawa, Takao Kato, Norihide Izumi, Erina Hosoya, Ayana Uchimura, Tadaaki Inano, Shuichi Shirane, Yutaka Tsukune, Tomoiku Takaku, Yasuharu Hamano, Miki Ando
- Journal Title
  
  British Journal of Haematology
  
  Volume: 205 Issue: 4 Pages: 1610-1614
- DOI
  10.1111/bjh.19652
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24K02330
[Journal Article] Eleven cases of laryngeal edema after tisagenlecleucel infusion: A 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomas2024
- Author(s)
  Erina Hosoya, Jun Ando, Shintaro Kinoshita, Yoshiki Furukawa, Yuko Toyoshima, Yoko Azusawa, Toru Mitsumori, Eriko Sato, Hina Takano, Yutaka Tsukune, Naoki Watanabe, Tomoiku Takaku, Hajime Yasuda, Yasuharu Hamano, Makoto Sasaki, Shuko Nojiri, Midori Ishii, and Miki Ando
- Journal Title
  
  Haematologica
  
  Volume: 110 Pages: 777-783
- DOI
  10.3324/haematol.2024.286169
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24K02330, KAKENHI-PROJECT-24K14684
[Journal Article] Rejuvenated iPSC-derived GD2-directed CART cells harbor robust cytotoxicity against small cell lung cancer.2024
- Author(s)
  Shintaro Kinoshita, Midori Ishii, Jun Ando, Takaharu Kimura, Tomoyuki Yamaguchi, Sakiko Harada, Fumiyuki Takahashi, Kazutaka Nakashima, Yozo Nakazawa, Satoshi Yamazaki, Koichi Ohshima, Kazuhisa Takahashi, Hiromitsu Nakauchi, Miki Ando
- Journal Title
  
  Cancer Research Communications.
  
  Volume: 4 Pages: 723-737
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-24K02330
[Journal Article] Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis2024
- Author(s)
  Sato Shoko、Ishii Midori、Tachibana Kota、Furukawa Yoshiki、Toyota Tokuko、Kinoshita Shintaro、Azusawa Yoko、Ando Jun、Ando Miki
- Journal Title
  
  Experimental Hematology
  
  Volume: 130 Pages: 104132-104132
- DOI
  10.1016/j.exphem.2023.11.006
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24K02330
[Journal Article] Successful management of acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline DDX41-mutated acute myeloid leukemia2024
- Author(s)
  Ayana Uchimura, Hajime Yasuda, Hiroko Onagi, Tadaaki Inano, Shuichi Shirane, Midori Ishii, Yoko Azusawa, Yasuharu Hamano, Hidetaka Eguchi, Masami Arai, Jun Ando, Miki Ando
- Journal Title
  
  Heliyon
  
  Volume: 10 Issue: 2 Pages: e24801-e24801
- DOI
  10.1016/j.heliyon.2024.e24801
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24K02330
[Journal Article] iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma2021
- Author(s)
  Ishii Midori、Ando Jun、Yamazaki Satoshi、Toyota Tokuko、Ohara Kazuo、Furukawa Yoshiki、Suehara Yoshiyuki、Nakanishi Mahito、Nakashima Kazutaka、Ohshima Koichi、Nakauchi Hiromitsu、Ando Miki
- Journal Title
  
  Cancer Immunology Research
  
  Volume: 9 Issue: 10 Pages: 1175-1186
- DOI
  10.1158/2326-6066.cir-21-0193
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07781, KAKENHI-PROJECT-20K21612, KAKENHI-PUBLICLY-20H05025, KAKENHI-PROJECT-20H03707, KAKENHI-PROJECT-19J40304, KAKENHI-PROJECT-21F21108, KAKENHI-PROJECT-21K07249, KAKENHI-PROJECT-19K22694, KAKENHI-PROJECT-19H03789
[Patent] ＣＤ４陽性Ｔ細胞の製造方法2024
- Inventor(s)
  安藤美樹、安藤純、石井翠、古川芳樹、中内啓光
- Industrial Property Rights Holder
  安藤美樹、安藤純、石井翠、古川芳樹、中内啓光
- Industrial Property Rights Type
  特許
- Filing Date
  2024
- Overseas
- Data Source
  KAKENHI-PROJECT-24K02330
[Presentation] iPSC-derived neoantigen-specific cytotoxic T lymphocyte therapy for Ewing sarcoma.2021
- Author(s)
  M Ishii, J Ando, T Toyota, K Ohara, H Nakauchi, M Ando.
- Organizer
  ISSCR 2021, Virtual
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19J40304
[Presentation] Ewing肉腫のネオアンチゲンを標的とするiPS細胞由来細胞傷害性T細胞療法の抗腫瘍効果についての検討2020
- Author(s)
  石井翠、安藤美樹、豊田釈子、小原和男、松岡里沙、末原義之、安藤純、金子和夫、小松則夫、中内啓光
- Organizer
  日本整形外科学会基礎学術集会
- Data Source
  KAKENHI-PROJECT-19J40304
[Presentation] Ewing肉腫のネオアンチゲンを標的とするiPS細胞由来細胞傷害性T細胞療法の抗腫瘍効果についての検討2019
- Author(s)
  石井翠、安藤美樹、原田早希子、本田匡宏、末原義之、安藤純、小松則夫、中内啓光
- Organizer
  日本血液疾患免疫療法学会
- Data Source
  KAKENHI-PROJECT-19J40304
[Presentation] The neoantigen-specific iPSC-derived rejuvenated CTL therapy for Ewing sarcoma2019
- Author(s)
  Midori Ishii 1,2，Miki Ando 1,3，Yumi Sakiyama 1,3，Sakiko Harada， Tadahiro Honda，Jun Ando，Norio Komatsu，Hiromitsu Nakauchi
- Organizer
  日本血液学会総会
- Data Source
  KAKENHI-PROJECT-19J40304

1. 安藤美樹 (10424251)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
2. 安藤純 (60348943)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results

Ishii Midori 石井 翠

Research Projects

Research Products

Co-Researchers

他家iPSC由来HLA-A*0201拘束性TCR-T細胞療法のためのHLAゲノム編集技術の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The investigation of CD4/CD8 lineage choice and Th1 generation from iPSC

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of HLA-A24-restricted neoantigen-specific immunotherapy for Ewing sarcomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of the fusion gene-specific rejuvenated CTL therapy for Ewing sarcomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] L-asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein-Barr virus infection2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Eleven cases of laryngeal edema after tisagenlecleucel infusion: A 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomas2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Rejuvenated iPSC-derived GD2-directed CART cells harbor robust cytotoxicity against small cell lung cancer.2024

Author(s)

Journal Title

Data Source

[Journal Article] Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Successful management of acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline DDX41-mutated acute myeloid leukemia2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma2021

Author(s)

Journal Title

DOI

Data Source

[Patent] ＣＤ４陽性Ｔ細胞の製造方法2024

Inventor(s)

Industrial Property Rights Holder

Industrial Property Rights Type

Filing Date

Data Source

[Presentation] iPSC-derived neoantigen-specific cytotoxic T lymphocyte therapy for Ewing sarcoma.2021

Author(s)

Organizer

Data Source

[Presentation] Ewing肉腫のネオアンチゲンを標的とするiPS細胞由来細胞傷害性T細胞療法の抗腫瘍効果についての検討2020

Author(s)

Organizer

Data Source

[Presentation] Ewing肉腫のネオアンチゲンを標的とするiPS細胞由来細胞傷害性T細胞療法の抗腫瘍効果についての検討2019

Author(s)

Organizer

Data Source

[Presentation] The neoantigen-specific iPSC-derived rejuvenated CTL therapy for Ewing sarcoma2019

Author(s)

Organizer

Data Source

Ishii Midori 石井翠